A Clinical Study to Assess the Effectiveness of Oral Combination Kit Therapy in Syndromic Management of Abnormal Vaginal Discharge (FEMINE Study) in Kinshasa, Democratic Republic of Congo
Background: Vaginal discharge is one of most common and nagging problems that women
face. About 20%-25% of women who visit
gynecology department complain of vaginal discharge and leucorrhoea. An orally
administered combination kit, containing 2g
secnidazole, 1g azithromycin
and 150mg
fluconazole (Azimyn FS Kit), has been
successfully evaluated in clinical trials and used in several countries for
management syndromic vaginal discharge due to infections. Methods: This is a longitudinal
study which aimed to verify the clinical efficacy of the combined oral kit
containing secnidazole, azithromycin and fluconazole (Azimyn FS Kit？) in the
syndromic treatment of abnormal vaginal discharge in patients received in
outpatient consultations in Kinshasa/DR Congo from March to September 2023. Results: Majority of patients had
whitish vaginal discharge (51.6%) of average abundance (56.2%), accompanied by
pruritus in 72.1% of cases, and dyspareunia in 23.5% of cases and
hypogastralgia in 40.2% of cases. One week after treatment with the Azimyn FS？ combined
kit, at the greatest majority of patients (97.3%), abnormal vaginal discharge
had decreased by more than 50% (84.1%). Two weeks after treatment with the
Azimyn FS
References
[1]
Jogi, S.R. (2015) Vaginal Discharge: Evaluation of Syndromic Management in Chhattisgarh Institute of Medical Sciences, Bilaspur, CG. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 4, 1534-1538.
https://doi.org/10.18203/2320-1770.ijrcog20150691
[2]
Swetha, V., Kannan, G., Asha, D. and Kavitha, A. (2017) Epidemiology and Clinico-Investigative Study of Organisms Causing Vaginal Discharge. Indian Journal of Sexually Transmitted Diseases and Aids, 38, 69-75.
https://doi.org/10.4103/0253-7184.203433
[3]
Meena, V. and Bansal, C.L. (2016) Study to Assess Targeted Management and Syndromic Management in Women with Abnormal Vaginal Discharge. The Journal of Obstetrics and Gynecology of India, 66, 534-540.
https://doi.org/10.1007/s13224-016-0879-x
[4]
Murewanhema, G., Moyo, E., Mhango, M., Chitango, I., Moyo, P., Musuka, G., et al. (2022) Abnormal Vaginal Discharge in Women of Reproductive Age in Sub-Saharan Africa: The Need for a Paradigm Shift from a Syndromic Approach to Specific Pathogen Identification and Directed Treatment. IJID Regions, 29, 165-168.
https://doi.org/10.1016/j.ijregi.2022.10.006
[5]
Onyekonwu, C.L., Olumide, Y.M., Oresanya, F.A. and Onyekonwu, G.C. (2011) Vaginal Discharge: Etiological Agents and Assessment of Syndromic Management in Lagos. Nigerian Journal of Medicine, 20, 155-162.
[6]
Rubio-Sanchez, R., Rios-Reina, R. and Ubeda, C. (2023) Identification of Volatile Biomarkers of Trichomonas vaginalis Infection in Vaginal Discharge and Urine. Applied Microbiology and Biotechnology, 107, 3057-3069.
https://doi.org/10.1007/s00253-023-12484-6
[7]
Bruins, M.J., Dos Santos, C.O., Damoiseaux, R.A.M.J. and Ruijs, G.J.H.M. (2021) Bacterial Agents in Vulvovaginitis and Discharge Vaginas: A 10-Year Retrospective Study in the Netherlands. European Journal of Clinical Microbiology & Infectious Diseases, 40, 2123-2128. https://doi.org/10.1007/s10096-021-04265-8
[8]
Reiter, S. and Kellogg, S. (2019) Bacterial Vaginosis: An Introduction for Clinicians. Postgraduate Medicine, 131, 8-18. https://doi.org/10.1080/00325481.2019.1546534
[9]
Majigo, M.V., Kashindye, P., Mtulo, Z. and Joachim, A. (2021) Bacterial Vaginosis, the Leading Cause of Genital Discharge among Women Presenting with Vaginal Infection in Dar es Salaam, Tanzania. African Health Sciences, 21, 531-537.
https://doi.org/10.4314/ahs.v21i2.7
[10]
Dukers-Muijrers, N.H.T.M., Wolffs, P.F.G., De Vries, H., Götz, H.M., Heijman, T., Bruisten, S., Eppings, L., Hogewoning, A., Steenbakkers, M., Lucchesi, M., Schim van der Loeff, M.F. and Hoebe, C.J.P.A. (2019) Treatment Effectiveness of Azithromycin and Doxycycline in Uncomplicated Rectal and Vaginal Chlamydia trachomatis Infections in Women: A Multicenter Observational Study (FemCure). Clinical Infectious Diseases, 69, 1946-1954. https://doi.org/10.1093/cid/ciz050
[11]
Romero Herrero, D. and Andreu Domingo, A. (2016) Vaginosis Bacteriana [Bacterial Vaginosis]. Enfermedades Infecciosas y Microbiología Clínica, 34, 14-18.
https://doi.org/10.1016/S0213-005X(16)30214-2
[12]
Shailesh, K., Anahita, P., Sangeeta, K., Santosh, P., Sheetal, K., Patani, K.V., et al. (2021) Syndromic Management of Vaginal Discharge Our Experience. The Journal of Obstetrics and Gynecology of India, 1, 9.
[13]
Mogtomo, M.L.K., Njiki, A.N., Longang, A.-M., Foko, L.P.K., Embolo, E., Kom, B., et al. (2016) Prévalence des germes impliqués dans les infections vaginales chez les femmes camerounaises et facteurs de risque. International Journal of Biological and Chemical Sciences, 10, 255-268. https://doi.org/10.4314/ijbcs.v10i1.20
[14]
Khan, M., Ahmed, J., Gul, A., Ikram, A. and Lalani, F.K. (2018) Antifungal Susceptibility Testing of Vulvovaginal Candida Species among Women Attending Antenatal Clinic in Tertiary Care Hospitals of Peshawar. Infection and Drug Resistance, 11, 447-456. https://doi.org/10.2147/IDR.S153116
[15]
Yassin, M.T., Mostafa, A.A., Al-Askar, A.A. and Bdeer, R. (2020) In Vitro Antifungal Resistance Profile of Candida Strains Isolated from Saudi Women Suffering from Vulvovaginitis. European Journal of Medical Research, 25, Article No. 1.
https://doi.org/10.1186/s40001-019-0399-0
Angel-Muller, E., Rubio-Romero, J.A., Rodriguez-Hernandez, A. and Ruiz-Para, A. (2014) Effectiveness and Safety of the Combination of Fluconazole and Secnidazole for the Treatment of Symptomatic Vaginal Discharge: Bogota, Colombia. Revista Colombiana de Obstetricia y Ginecología, 65, 32-40.
https://doi.org/10.18597/rcog.77
[18]
Al Quaiz, J.M. (2000) Patients with Vaginal Discharge: A Survey in a University Primary Care Clinic in Riyadh City. Annals of Saudi Medicine, 20, 302-306.
https://doi.org/10.5144/0256-4947.2000.302
[19]
Dukers-Muijrers, N., Wolffs, P., De Vries, H., Götz, H.M., Heijman, T., Bruisten, S., et al. (2019) Efficacité du traitement de l’azithromycine et de la doxycycline dans les infections rectales et vaginales à Chlamydia trachomatis non compliquées chez les femmes: Une étude observationnelle multicentrique. Clinical Infectious Diseases, 69, 1946-1954. https://doi.org/10.1093/cid/ciz050
[20]
Venugopal, S., Gopalan, K., Devi, A. and Kavitha, A. (2017) épidémiologie et étude clinico-investigative des organismes responsables des pertes vaginales. Indian Journal of Sexually Transmitted Diseases and AIDS, 38, 69-75.
https://doi.org/10.4103/0253-7184.203433
[21]
Fanou, B.A., Klotoe, J.R., Dougnon, V., Monteiro, A., Koudokpon, C.H. and Loko, F. (2022) Prévalence et facteurs associés aux candidoses vulvovaginales chez les femmes admises en consultation à l’Hôpital de Zone de Mènontin (Bénin). Pan African Medical Journal, 42, Article No. 215.
https://doi.org/10.11604/pamj.2022.42.215.28984
[22]
Sylla, K., Sow, D., Lakhe, N.A., Tine, R.C., Dia, M., Lelo, S., et al. (2018) Candidoses vulvo-vaginales au laboratoire de Parasitologie-Mycologie du Centre Hospitalier Universitaire de Fann, Dakar (Sénégal). Revue Cames Santé, 5, 21-27.
[23]
Pizzorno, J.E., Murray, M.T. and Joiner-Bey, H. (2016) Intestinal Protozoan Infestation and Systemic Illness. In: Pizzorno, J.E., Murray, M.T. and Joiner-Bey, H., Eds., The Clinician’s Handbook of Natural Medicine, Elsevier, Amsterdam, 574-578.
https://doi.org/10.1016/B978-0-7020-5514-0.00055-5
[24]
Hillier, S.L., Austin, M., Macio, I., Meyn, L.A., Badway, D. and Beigi, R. (2021) Diagnosis and Treatment of Vaginal Discharge Syndromes in Community Practice Settings. Clinical Infectious Diseases, 72, 1538-1543.
https://doi.org/10.1093/cid/ciaa260
[25]
Deka, S., Siddhesh, S., Neelesh, K. and Umesh, K. (2018) Assessment of a Dazel-Kit (Fluconazole 150 Mg, Azithromycin 1 Gm, Secnidazole 1 G Two Tablets) for Syndromic Management of Abnormal Vaginal Discharge in Women of Kazakhstan. International Journal of Research and Reports in Gynaecology, 1, 1-7.
[26]
Malhotra, M., Sharma, J.B., Batra, S. and Arora, R. (2003) Ciprofloxacin-Tinidazole Combination, Fluconazole-Azithromycin-Secnidazole-Kit and Doxycycline-Metronidazole Combination Therapy in Syndromic Management of Pelvic Inflammatory Disease: A Prospective Randomized Controlled Trial. Indian Journal of Medical Sciences, 57, 549-555.
[27]
Nunez, J.T. and Gomez, G. (2005) Low-Dose Secnidazole in the Treatment of Bacterial Vaginosis. International Journal of Gynecology & Obstetrics, 88, 281-285.
https://doi.org/10.1016/j.ijgo.2004.11.028
[28]
Rustomjee, R., Kharsany, A.B.M., Connolly, C.A. and Karim, S.S.A. (2002) A Randomized Controlled Trial of Azithromycin versus Doxycycline/Ciprofloxacin for the Syndromic Management of Sexually Transmitted Infections in a Resource-Poor Setting. Journal of Antimicrobial Chemotherapy, 49, 875-878.
https://doi.org/10.1093/jac/dkf034
[29]
Kularatne, R., Muller, E., Maseko, Y., Dias, B.D.C. and Kufa, T. (2022) Etiologic Surveillance of Vaginal Discharge Syndrome in South Africa: 2019 to 2020. Sexually Transmitted Diseases, 49, 565-570. https://doi.org/10.1097/OLQ.0000000000001646
[30]
Jobi, S.R. (2015) Vaginal Discharge: Evaluation of Syndromic Management in Chhattisgarh Institute of Medical Sciences, Bilaspur, C. G. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 4, 1534-1538.
https://doi.org/10.18203/2320-1770.ijrcog20150691
[31]
Chawla, M., Sharma, J.B., Batra, S. and Arora, R. (2004) Ciprofloxacin-Tinidazole Combination, Fluconazole-Azithromycin-Secnidazole-Kit and Doxycycline-Metronidazole Combination Therapy in Syndromic Management of Pelvic Inflammatory Disease: A Prospective Randomized Controlled Trial. Indian Journal of Medical Sciences, 57, 549-555.
[32]
Sharma, J., Chanana, C., Mittal, S. and Raina, U. (2005) A Prospective Study of Comparison of Efficacy of Two Combination Treatment of Pelvic Inflammatory Disease. The Internet Journal of Gynecology and Obstetrics, 5, 1-5.
